To determine the effect of orlistat plus a hypocaloric diet on change in body weight over 52 weeks in obese hypertensive patients inadequately controlled with antihypertensive medication(s). To determine the effect of orlistat plus a hypoclaroic diet on sitting diastolic blood pressure control over 52 weeks in obese hypertensive patients inadequately controlled with antihypertensive medication(s).Secondary objectives: To determine the percentage of patients treated with orlistat plus a hypocaloric diet compared to placebo plus hypocaloric diet achieve a diastolic blood pressure <9.0 mmHg or a decrease in sitting diastolic blood pressure of greater than 10 mmHg from baseline. To determine the percentage of patients treated with orlistat plus a hypocaloric diet compared to placebo plus hypocaloric diet achieving at least 5% reduction in body weight from baseline. To determine the effect of orlistat plus a hypocaloric diet on sitting systolic blood pressure control in obese hypertensive patients inadequately controlled with antihypertensive medication(s). To determine the effect of orlistat plus a hypocaloric diet on fasting lipid profile (total cholesterol, HDL, LDL, LDL/HDL ratio and triglycerides) and waist circumference. To assess the safety of orlistat in this population.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
24
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Kelly, Clare B; Hookham, Michelle B; Yu, Jeremy Y et al. (2018) Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 41:120-127
Putterman, Chaim; Pisetsky, David S; Petri, Michelle et al. (2018) The SLE-key test serological signature: new insights into the course of lupus. Rheumatology (Oxford) 57:1632-1640
Hall, Jordan T; Ebeling, Myla; Shary, Judy R et al. (2018) The relationship between physical activity and vitamin D status in postpartum lactating and formula-feeding women. J Steroid Biochem Mol Biol 177:261-265
Kelly, Clare B; Hookham, Michelle B; Yu, Jeremy Y et al. (2018) Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127. Diabetes Care 41:e102-e103
Bell, Katherine A; Wagner, Carol L; Perng, Wei et al. (2018) Validity of Body Mass Index as a Measure of Adiposity in Infancy. J Pediatr 196:168-174.e1
Sen, Sarbattama; Penfield-Cyr, Annie; Hollis, Bruce W et al. (2017) Maternal Obesity, 25-Hydroxy Vitamin D Concentration, and Bone Density in Breastfeeding Dyads. J Pediatr 187:147-152.e1
Wolf, Bethany J; Spainhour, John C; Arthur, John M et al. (2016) Development of Biomarker Models to Predict Outcomes in Lupus Nephritis. Arthritis Rheumatol 68:1955-63
Wagner, C L; Baggerly, C; McDonnell, S et al. (2016) Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. J Steroid Biochem Mol Biol 155:245-51
Hollis, Bruce W; Wagner, Carol L (2016) Response to commentary by D Roth. Evid Based Med 21:120
Basu, Arpita; Yu, Jeremy Y; Jenkins, Alicia J et al. (2015) Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutr Res 35:421-30

Showing the most recent 10 out of 395 publications